Accordingly, we demonstrated that Ginsenoside Rg3 may adjust the expression of SOX2 and the PI3K/AKT/mTOR signaling axis by up-regulating miR-429 in cisplatin-resistant GC cells (Figure 5). Here, SOX2 is linked to gastric cancer.